Skip to main content

-

Technology Guidance - Drug

Trastuzumab for treatment of metastatic breast cancer Guidance is outdated and has been withdrawn on 1 September 2020.
Please refer to the updated recommendations on Trastuzumab for treating HER2-positive breast and gastric cancers here.



Get Acrobat Readeropens in a new window
Back to Top